CIRBP and non-small cell lung carcinoma: Our Kaplan–Meier analysis indicated that NSCLC patients with higher expression of circ_0007386, lower expression of miR-383-5p, and higher expression of CIRBP experienced worse overall survival rates (Fig. 9A–C).